CIK 0001061983
- Large accelerated filer
CYTOKINETICS INC
Sign in to watch- Ticker
- CYTK
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 943291317
- Phone
- +1 650-624-3000
- Business address
- 350 OYSTER POINT BOULEVARD, ., SOUTH SAN FRANCISCO, CA, 94080
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $13,320,469
- in 18 filings, $12.5M under 10b5-1 plans
Net −$13,320,469. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Blum Robert I −$9.7M President & CEO sold 34% of stake
- Malik Fady Ibraham −$1.3M EVP Research & Development sold 12% of stake
- Hessekiel Jeffrey −$795K Chief Legal & Admin Officer sold 14% of stake
- Callos Andrew −$702K EVP, Chief Commercial Officer sold 15% of stake
- PARSHALL B LYNNE −$631K Director sold 63% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-04-03 | HENDERSON JOHN T Director | Grant or award | +530 | $37.71 | $20K | 25,420 |
| 2023-04-03 | Kaye Edward M. MD Director | Grant or award | +298 | $37.71 | $11K | 13,347 |
| 2023-04-03 | SMITH SANDFORD D Director | Grant or award | +298 | $37.71 | $11K | 12,831 |
| 2023-04-03 | WIERENGA WENDALL Director | Grant or award | +298 | $37.71 | $11K | 12,831 |
| 2023-04-03 | Wysenski Nancy Director | Grant or award | +149 | $37.71 | $6K | 11,671 |
| 2023-03-28 | Blum Robert I President & CEO | Exercise or conversion | +12,500 | $9.65 | $121K | 453,558 |
| 2023-03-28 | Blum Robert I President & CEO | Sale | −12,500 | $35.05 | $438K | 441,058 |
| 2023-03-28 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) | −12,500 | 108,191 | ||
| 2023-03-15 | Blum Robert I President & CEO | Exercise or conversion | +12,500 | $9.65 | $121K | 453,558 |
| 2023-03-15 | Blum Robert I President & CEO | Sale | −12,500 | $37.26 | $466K | 441,058 |
| 2023-03-15 | Blum Robert I President & CEO | Exercise or conversion · Non-Qualified Stock Option (Right to Buy) | −12,500 | 120,691 | ||
| 2023-03-09 | Malik Fady Ibraham EVP Research & Development | Sale | −4,000 | $39.10 | $156K | 171,183 |
| 2023-03-06 | Wong Robert VP, Chief Accounting Officer | Grant or award | +6,000 | 27,613 | ||
| 2023-03-06 | Wong Robert VP, Chief Accounting Officer | Grant or award · Incentive Stock Option (Right to Buy) | +2,464 | 2,464 | ||
| 2023-03-06 | Wong Robert VP, Chief Accounting Officer | Grant or award · Non-Qualified Stock Option (Right to Buy) | +9,536 | 9,536 | ||
| 2023-03-06 | Malik Fady Ibraham EVP Research & Development | Grant or award | +40,000 | 175,183 | ||
| 2023-03-06 | Malik Fady Ibraham EVP Research & Development | Grant or award · Incentive Stock Option (Right to Buy) | +2,555 | 2,555 | ||
| 2023-03-06 | Malik Fady Ibraham EVP Research & Development | Grant or award · Non-Qualified Stock Option (Right to Buy) | +77,445 | 77,445 | ||
| 2023-03-06 | Jaw Ching SVP Finance & CFO | Grant or award | +30,000 | 87,346 | ||
| 2023-03-06 | Jaw Ching SVP Finance & CFO | Grant or award · Incentive Stock Option (Right to Buy) | +2,555 | 2,555 |
Page 43 of 45 · 885 trades